CY1117600T1 - DIAZORAZOLI CODES AND ITS PRODUCERS WITH CELLULAR CONNECTORS, NEW DIAZORAZOLI PRODUCERS, METHODS OF PRODUCTION, AND THEIR USES - Google Patents

DIAZORAZOLI CODES AND ITS PRODUCERS WITH CELLULAR CONNECTORS, NEW DIAZORAZOLI PRODUCERS, METHODS OF PRODUCTION, AND THEIR USES

Info

Publication number
CY1117600T1
CY1117600T1 CY20161100492T CY161100492T CY1117600T1 CY 1117600 T1 CY1117600 T1 CY 1117600T1 CY 20161100492 T CY20161100492 T CY 20161100492T CY 161100492 T CY161100492 T CY 161100492T CY 1117600 T1 CY1117600 T1 CY 1117600T1
Authority
CY
Cyprus
Prior art keywords
diazorazoli
producers
methods
cellular
connectors
Prior art date
Application number
CY20161100492T
Other languages
Greek (el)
Inventor
Eckhard Günther
Olaf Schaefer
Michael Teifel
Klaus Paulini
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06018750A external-priority patent/EP1900742A1/en
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Publication of CY1117600T1 publication Critical patent/CY1117600T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει συζυγή διζοραζολίων και τα παράγωγα τους με μόρια κυτταρικής σύνδεσης, όπως πεπτίδια, πρωτεΐνες, ορμόνες, πρωτεΐνες αίματος και αντισώματα. Η παρούσα εφεύρεση παρέχει περαιτέρω νέα παράγωγα διζοραζολίου και μεθόδους παραγωγής τέτοιων συζυγών και παραγώγων διζοραζολίου. Αυτές οι ενώσεις μπορούν να χρησιμοποιηθούν ως φάρμακα για τη θεραπεία φυσιολογικών και/ή παθοφυσιολογικών καταστάσεων σε θηλαστικά, συγκεκριμένα για τη θεραπεία ποικίλων όγκων.The present invention provides a conjugate of diazorazoles and their derivatives with cellular binding molecules, such as peptides, proteins, hormones, blood proteins and antibodies. The present invention further provides novel diisorazole derivatives and methods of producing such conjugates and diisorazole derivatives. These compounds can be used as medicaments for the treatment of physiological and / or pathophysiological conditions in mammals, in particular for the treatment of various tumors.

CY20161100492T 2006-09-06 2016-06-03 DIAZORAZOLI CODES AND ITS PRODUCERS WITH CELLULAR CONNECTORS, NEW DIAZORAZOLI PRODUCERS, METHODS OF PRODUCTION, AND THEIR USES CY1117600T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84235706A 2006-09-06 2006-09-06
EP06018750A EP1900742A1 (en) 2006-09-07 2006-09-07 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
EP07803270.3A EP2066679B1 (en) 2006-09-06 2007-09-06 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

Publications (1)

Publication Number Publication Date
CY1117600T1 true CY1117600T1 (en) 2017-04-26

Family

ID=58606644

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100492T CY1117600T1 (en) 2006-09-06 2016-06-03 DIAZORAZOLI CODES AND ITS PRODUCERS WITH CELLULAR CONNECTORS, NEW DIAZORAZOLI PRODUCERS, METHODS OF PRODUCTION, AND THEIR USES

Country Status (1)

Country Link
CY (1) CY1117600T1 (en)

Similar Documents

Publication Publication Date Title
CY1120670T1 (en) MONOCLONIC ANTIBODIES AGAINST TISSUE FACTOR INHIBITOR (TFPI)
CY1122195T1 (en) SERPIN FUSION POLYPEPTIDES AND METHODS OF USING THEM
CY1118979T1 (en) ANTIBODIES DIRECTED AGAINST HER-3 AND USE OF THESE
CY1116823T1 (en) ABCB5 TARGETING FOR CANCER TREATMENT
CY1122346T1 (en) MONOCLONAL ANTIBODIES AGAINST CLAUDIN 18 FOR THE TREATMENT OF CANCER
CY1116264T1 (en) ANTIBODIES AGAINST HUMAN VASCULAR 2
CY1117963T1 (en) IL-17A AND IL-17F ANTIBODIES
CY1122412T1 (en) HOMOPOLAR DISSOBATES AND THEIR USES
CY1111065T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN OMEGA-CARBOXYRYL SUBSTITUTED DIFFINYL URINARY FOR CANCER TREATMENT
CY1118693T1 (en) ANTI-ACTIVE AIDS AND USE OF THESE
CY1118845T1 (en) ANTIGEN CONCENTRATION BINDING PROTEINS A IL-17
CY1119647T1 (en) ALUMINUM ACCESSORIES AND ACCESSORIES FOR ACCESSORIES
CY1119591T1 (en) SPECIAL CONNECTION PROTEINS AND THEIR USES
CY1112495T1 (en) CYTAROTOXIC FACTORS INCLUDING NEW TOMAIMYKIN PRODUCERS
CY1118554T1 (en) BACKGROUND STABILIZED FAB b
CY1119233T1 (en) GENE PRODUCTS DIFFERENTLY DIFFERENT IN MEDICINES AND APPLICATIONS
CY1113160T1 (en) ARYLURIA COMPOUNDS IN CONNECTION WITH OTHER CELLULAR OR CELLULAR MEDICINES FOR HUMAN CANCER TREATMENT
CY1114922T1 (en) Cytotoxic agents which include new tomomycin derivatives and their therapeutic use
CY1113243T1 (en) METHODS OF TREATMENT USING CTLA-4
NO20083891L (en) Anti-5T4 antibodies and uses thereof
DE602004025101D1 (en) HUMAN ANTI-HUMANE CD3 BONDING MOLECULES
CY1120123T1 (en) GT468 MONOCLONIC ANTIBODIES FOR CANCER TREATMENT
CY1113089T1 (en) Human Monoclonal Antibodies to Specific Protective Membrane Antigen (PSMA)
CY1123743T1 (en) IGF-IR ANTIBODY AND ITS USE AS A TARGETING VEHICLE FOR CANCER TREATMENT
CY1107426T1 (en) NEW PRODUCTS OF FLUORIOGYCLIDES FROM PYRAZOLS, PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS AND USE OF THESE